Metraipolis › archive › dc_c58d4701d655
Metabolic reprogramming-driven stratification and therapeutic targeting in lung adenocarcinoma: implications for prognosis and personalized treatment — Europe PMC PMID:41561767
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41561767
- DOI
- 10.3389/fonc.2025.1696117
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:44:55.768Z
- SHA-256 of the archived text
cdba2785c029eb8c6e1a4ecc6029e427c8d8bdbe3cf2e268ad8a46a0d44c9623- Stable URL of this page
https://metraipolis.com/documento/dc_c58d4701d655
How to cite
Metabolic reprogramming-driven stratification and therapeutic targeting in lung adenocarcinoma: implications for prognosis and personalized treatment — Europe PMC PMID:41561767 — Europe PMC (en), https://europepmc.org/article/MED/41561767 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c58d4701d655 (Metraipolis archive dc_c58d4701d655, sha256 cdba2785c029eb8c6e1a4ecc6029e427c8d8bdbe3cf2e268ad8a46a0d44c9623)
BibTeX
@misc{dcc58d4701d655,
title = {Metabolic reprogramming-driven stratification and therapeutic targeting in lung adenocarcinoma: implications for prognosis and personalized treatment — Europe PMC PMID:41561767},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41561767},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c58d4701d655; sha256 cdba2785c029eb8c6e1a4ecc6029e427c8d8bdbe3cf2e268ad8a46a0d44c9623},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561767. Agents can read the archived copy with the MCP tool read_document.